Document is current
Any future updates will be listed below
-
Authors
Horvat, Natally
Jayaprakasam, Vetri Sudar
Crane, Christopher H.
Zheng, Junting
Gangai, Natalie
Romesser, Paul B.
Golia Pernicka, Jennifer S.
Capanu, Marinela
Gollub, Marc J. https://orcid.org/0000-0002-6008-0730
-
Funding
Funding for this research was provided by:
National Cancer Institute (P30 CA008748)
- License Information
-
More Information
Article History
Received: 13 October 2023
Revised: 12 January 2024
Accepted: 17 January 2024
First Online: 8 March 2024
Declarations
:
: Marc J. Gollub reports a relationship with GlaxoSmithKline that includes: consulting or advisory. Paul B. Romesser reports a relationship with XRAD Therapeutics and EMD Serono that includes: funding grants. The remaining authors have no relevant financial or non-financial interests to disclose.
: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Institutional Review Board of Memorial Sloan Kettering Cancer Center (Date of approval July 12, 2016 / No. 16-923).
: The need for informed consent was waived by the Institutional Review Board of Memorial Sloan Kettering Cancer Center in view of the retrospective nature of the study.
